
At least 2,500 people have been killed in Iran since protests broke out at the end of December, the Norway-based human rights organization Hengaw said on Tuesday.
The group noted that its verification team is working daily to document deaths linked to the state crackdown on mass protests.
On Tuesday, Iran Human Rights (IHRNGO), which is also registered in Norway, put the number of demonstrators killed at at least 734, but warned the real toll could be significantly higher, even in the thousands.
"Due to the complete internet shutdown since Thursday night and the severe restrictions on access to information, independent verification of these figures is currently extremely difficult," the IHRNGO report said.
Iranians have been demonstrating for more than two weeks against the authoritarian rule of the Islamic Republic. The protests, triggered by an economic crisis, have meanwhile taken on a nationwide dimension.
Iran has defended its actions against the unrest, justifying the use of force by saying that those taking part were "terrorists" or "rioters."
latest_posts
- 1
Netflix Faces Wider Fallout After Italy Court Orders Refunds, Price Cuts - 2
Merz postpones Norway trip for Belgium talks on frozen Russian assets - 3
Find the Advantages of Innovative Leisure activities: Supporting Creative mind and Self-Articulation - 4
Italy's Beloved Trevi Fountain Hides A Unique Secret That Can Be Explored Underground - 5
5 Family SUVs for 2024: Which One Accommodates Your Family's Needs\uff1f
Vote in favor of your Favored Travel Movement
Strength training is crucial after menopause. How to make the most of your workouts
Several killed in Ukraine and Russia after cross-border attacks
6 Pet Sitting Administrations for Your Cherished Pets
How AI fixed the James Webb Space Telescope's blurry vision
Why this Tennessee special election has the 'whole world' watching
The Most Compelling Innovation Advancements Somewhat recently
Who plays Moana in the live-action remake? What to know about Catherine Lagaʻaia.
Corcept Therapeutics shares surge as lead drug gets FDA nod for ovarian cancer










